Federal contractors / ESSENTIAL ACCESS HEALTH

Federal contract award

75N94023F00001

OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NICHD
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle75N94020D00015
Set-asideNot reported
Pricing typeCOST NO FEE
Obligations$349.3K
Current contract value$349.3K
Potential contract value / ceiling$349.3K
Start dateSep 28, 2023
Current end dateMay 30, 2025
Potential end dateMay 30, 2025
Latest award activityMar 26, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 26, 2025P00002$0NICHD: R&D: OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL
Sep 26, 2024P00001$0OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL
Sep 26, 20230$349.3KOVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.